Arijit Barman is joined by Adar Poonawalla, CEO, Serum Institute of India, at the World Economic Forum 2025 where he sheds light on concerns around Trump’s pullout from the WHO, progress in achieving vaccine equity, status of key projects like the HPV vaccine to combat cervical cancer, and upcoming vaccines for malaria, dengue, and chikungunya. He also discusses the institute’s $2 billion investment in cutting-edge research and facilities, the use of AI to aid clinical trials, and the development of needle-free vaccine delivery methods. Beyond healthcare, Poonawalla highlights his strategic diversification from financial services and insurance to films and music labels.

Tune in:.

If you like this episode, check out more Corner Office Conversations from the podcast: S. Jaishankar, Ravi Kant Jaipuria,Arjun Nohwar, Manoj Chacko, G.V. Prasad, Dara Khosrowshahi, Henry Kravis, Campbell Wilson, Warren K. Harris,Nithin Kamath, Corner Office Conversation With Monika Shergill, VP, Content, Netflix India and more!

You can follow our host Arijit Barman on his social media: Twitter and Linkedin

Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts,JioSaavn, Amazon Music and Google Podcasts.

See omnystudio.com/listener for privacy information.

ET@Davos: Corner Office Conversation with Adar Poonawalla

The Morning Brief

ET@Davos: Corner Office Conversation with Adar Poonawalla